Literature DB >> 26460319

Genetic studies of rheumatoid arthritis.

Kazuhiko Yamamoto1, Yukinori Okada, Akari Suzuki, Yuta Kochi.   

Abstract

Rheumatoid arthritis (RA) is a common autoimmune disease that results in significant morbidity. As with other complex disorders, genome-wide association studies (GWASs) have greatly contributed to the current understanding of RA etiology. In this review, we describe the genetic configuration of RA as revealed primarily through GWASs and their meta-analyses. In addition, we discuss the pathologic mechanisms of RA as suggested by the findings of genetic and functional studies of individual RA-associated genes, including HLA-DRB1, PADI4, PTPN22, CCR6 and FCRL3, and the potential use of genetic information for RA treatment in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26460319      PMCID: PMC4729856          DOI: 10.2183/pjab.91.410

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  60 in total

Review 1.  Genes, environment and immunity in the development of rheumatoid arthritis.

Authors:  Lars Klareskog; Leonid Padyukov; Johan Rönnelid; Lars Alfredsson
Journal:  Curr Opin Immunol       Date:  2006-09-28       Impact factor: 7.486

2.  Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Authors:  S P Linn-Rasker; A H M van der Helm-van Mil; F A van Gaalen; M Kloppenburg; R R P de Vries; S le Cessie; F C Breedveld; R E M Toes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

3.  Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis.

Authors:  K Ikari; S Momohara; T Nakamura; M Hara; H Yamanaka; T Tomatsu; N Kamatani
Journal:  Ann Rheum Dis       Date:  2005-09-21       Impact factor: 19.103

4.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

5.  Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.

Authors:  M J Simmonds; J M Heward; J Carr-Smith; H Foxall; J A Franklyn; S C L Gough
Journal:  J Clin Endocrinol Metab       Date:  2005-12-29       Impact factor: 5.958

6.  Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.

Authors:  Jonathan A Hill; Scott Southwood; Alessandro Sette; Anthony M Jevnikar; David A Bell; Ewa Cairns
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

7.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

Authors:  Floris A van Gaalen; Jill van Aken; Tom W J Huizinga; Geziena M Th Schreuder; Ferdinand C Breedveld; Eric Zanelli; Walther J van Venrooij; Cornelis L Verweij; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2004-07

8.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

9.  HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity.

Authors:  A MacGregor; W Ollier; W Thomson; D Jawaheer; A Silman
Journal:  J Rheumatol       Date:  1995-06       Impact factor: 4.666

10.  Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.

Authors:  T Furuya; M Hakoda; N Ichikawa; K Higami; Y Nanke; T Yago; T Kobashigawa; K Tokunaga; N Tsuchiya; N Kamatani; S Kotake
Journal:  Clin Exp Rheumatol       Date:  2007 Mar-Apr       Impact factor: 4.473

View more
  15 in total

1.  Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis.

Authors:  Yukinori Okada; Akari Suzuki; Katsunori Ikari; Chikashi Terao; Yuta Kochi; Koichiro Ohmura; Koichiro Higasa; Masato Akiyama; Kyota Ashikawa; Masahiro Kanai; Jun Hirata; Naomasa Suita; Yik-Ying Teo; Huji Xu; Sang-Cheol Bae; Atsushi Takahashi; Yukihide Momozawa; Koichi Matsuda; Shigeki Momohara; Atsuo Taniguchi; Ryo Yamada; Tsuneyo Mimori; Michiaki Kubo; Matthew A Brown; Soumya Raychaudhuri; Fumihiko Matsuda; Hisashi Yamanaka; Yoichiro Kamatani; Kazuhiko Yamamoto
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

Review 2.  Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.

Authors:  Xinqiang Song; Qingsong Lin
Journal:  Rheumatol Int       Date:  2017-05-10       Impact factor: 2.631

3.  Tumor necrosis factor-α -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-α.

Authors:  Mohd Jahid; Puja Kumari Jha; Diwesh Chawla; Rajnish Avasthi; Rafat Sultana Ahmed
Journal:  Clin Rheumatol       Date:  2017-07-27       Impact factor: 2.980

Review 4.  The Mechanisms Underlying Chronic Inflammation in Rheumatoid Arthritis from the Perspective of the Epigenetic Landscape.

Authors:  Yasuto Araki; Toshihide Mimura
Journal:  J Immunol Res       Date:  2016-12-28       Impact factor: 4.818

5.  Prognostic significance of high-mobility group box protein 1 genetic polymorphisms in rheumatoid arthritis disease outcome.

Authors:  Li-Hong Wang; Min-Huan Wu; Po-Chun Chen; Chen-Ming Su; Guohong Xu; Chien-Chung Huang; Chun-Hao Tsai; Yuan-Li Huang; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

Review 6.  Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.

Authors:  Yasuto Araki; Toshihide Mimura
Journal:  Int J Mol Sci       Date:  2017-04-25       Impact factor: 5.923

Review 7.  Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response.

Authors:  Dmitry S Mikhaylenko; Marina V Nemtsova; Irina V Bure; Ekaterina B Kuznetsova; Ekaterina A Alekseeva; Vadim V Tarasov; Alexander N Lukashev; Marina I Beloukhova; Andrei A Deviatkin; Andrey A Zamyatnin
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

8.  An Updated Meta-Analysis of the Associations Between MicroRNA Polymorphisms and Susceptibility to Rheumatoid Arthritis.

Authors:  Mi Zhou; Bo Jiang; Mao Xiong; Xin Zhu
Journal:  Front Physiol       Date:  2018-11-15       Impact factor: 4.566

9.  Aggregation of experts: an application in the field of "interactomics" (detection of interactions on the basis of genomic data).

Authors:  Sinan Abo Alchamlat; Frédéric Farnir
Journal:  BMC Bioinformatics       Date:  2018-11-21       Impact factor: 3.169

10.  Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.

Authors:  Morten L Halling; Jens Kjeldsen; Torben Knudsen; Jan Nielsen; Lars Koch Hansen
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.